Treatment of Relapsed Follicular Lymphoma with FCR and Radioimmunotherapy
Author Information
Author(s): Francesco Pisani, Carlo Ludovico Maini, Rosa Sciuto, Laura Dessanti, Mariella D'Andrea, Daniela Assisi, Maria Concetta Petti
Primary Institution: Regina Elena National Cancer Institute
Hypothesis
Is the combination of FCR followed by 90Y-RIT effective for treating relapsed grades 1 and 2 follicular lymphoma?
Conclusion
The study shows that FCR followed by 90Y-RIT is feasible, tolerable, and effective for patients with relapsed grades 1 and 2 follicular lymphoma.
Supporting Evidence
- Seven patients achieved complete remission after FCR.
- Two patients converted from partial remission to complete remission after 90Y-RIT.
- Overall survival rates were 89% at 2 years, 76% at 3 years, and 61% at 4 years.
Takeaway
Doctors treated 9 patients with a specific medicine combination for a type of cancer, and most of them got better.
Methodology
Patients received FCR followed by 90Y-RIT and were monitored for response and side effects.
Potential Biases
Potential bias due to the retrospective nature of the study and lack of a control group.
Limitations
The study is retrospective and includes a small sample size.
Participant Demographics
Median age was 63 years, with a range of 46-77 years; 3 males and 6 females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website